this could be helpful in selecting those patients who would potentially benefit from the KD and who should be encouraged to continue the diet.
The frequency of interictal epileptic discharges (IEDs) is a potential predictor for response to treatments. The occurrence of IEDs is correlated to seizure recurrence. 11, 12 IED frequency is correlated with seizure-frequency, especially in patients with severe epilepsies. 13 In a recent study Kessler et al. 14 found that a response to the diet was 6 times more likely in children with a proportional IED index decline in wakefulness of 10% from baseline at one month of KD treatment.
In our centre, adults as well as children are treated with the KD. We examined whether early EEG changes during wakefulness or sleep 6 weeks after treatment initiation could be used to predict the response to the diet in subsequent months. We hypothesized that if a reduction of IEDs is seen soon after the initiation of the KD, this is related to a reduction in seizure frequency in subsequent months. Secondly, we examined whether baseline characteristics could predict the response to the KD.
Methods

Study design
We compared the IED-frequency in a 24-h ambulatory EEG after 6 weeks of treatment with the KD, to the IED-frequency in a baseline 24-h EEG one week before treatment (Fig. 1) . A period of 4 weeks treatment is necessary to obtain stable ketosis. We registered at 6 weeks in order to be early in the treatment phase together with a high chance of all patients being in a steady ketosis at that moment.
A change in IED-frequency was compared with the clinical outcome as defined by the mean seizure frequency during a followup period ranging from at least 2 to a maximum of 6 months compared to 2 months baseline. Seizure counts in the first month of KD introduction were not used to define clinical outcome, because this period was necessary to obtain ketosis.
Antiepileptic drugs (AED) were continued unchanged during baseline and the first six months of treatment with the KD. The only allowed exception was an urgent medical reason.
The study was approved by the Medical Ethics Committee according to Dutch Governmental Guidelines.
Ketogenic diet
The KD was introduced during a 2-week hospitalization according to the Dutch guideline for KD 15 . This guideline does not include a fasting period. Usually the MCT (medium chain triglyceride)-diet was applied but if the insurance company did not refund the diet products, or at the subject's request, the classical diet or modified Atkins diet (MAD) was used. Changes could be made to the MCT-diet because of side-effects and other problems during the introduction phase. When tube feeding was given, a liquid form of the classical KD was used. The start of the diet was defined as the first change made to the daily nutrition. During the KD, ketosis was frequently measured. During the second 24-h EEG, the ketosis was measured in urine and blood or only in blood in cases of incontinence.
Clinical outcome
Patients and/or caregivers were asked to register seizures in a diary starting two months prior to the introduction of the KD.
The mean seizure frequency during the follow-up period after the 4 weeks of KD introduction was calculated and compared to the baseline mean seizure frequency. When the mean seizure frequency was reduced by 50%, the patient was defined as being a clinical responder. If seizure diaries were incomplete, the treating physician was asked to define the patient as a responder or nonresponder, using patient's and/or caregiver's information. EEGs were recorded with the localizations Fp2, F4, C4, P4, O2,  F8, T4, T6, Fp1, F3, C3, P3, O1, F7, T3, T5 , Fp0, F0, C0, and P0. For the comparison of the IED-frequency before and after KD, two EEG scoring methods were used.
EEG analysis
EEG scoring method 1
The number of IEDs was visually counted during 2 h of wakefulness (1 h during the day and the first hour after awakening). If possible, the selection was taken from the same hours of the day for EEG 1 and EEG 2, to minimize the effects of circadian rhythm or drug level fluctuations on the IED index. The mean number of IEDs in these 2 h was used to calculate a % of time of IEDs: (number of seconds containing IEDs/total number of seconds)*100 (the IED index). The IED indices from 2 EEGs (baseline and EEG at 6 weeks) were combined to calculate the proportional reduction in % from the baseline index: (baseline index minus index at 6 weeks/baseline index)*100. The IED index was also calculated for the first hour of sleep. The beginning of sleep was defined as the disappearance of the occipital rhythm during the previous 5 min. When patients did not have an occipital rhythm, the beginning of sleep was defined as the disappearance of eye-blinks during the previous 5 min. No IEDs were counted in the period of 30 min after any major seizure (tonic-clonic seizure, complexpartial seizure, or tonic seizure) to avoid possible post-ictal changes. Two EEGs from the same patient were scored directly after each other. The reviewer was blinded for the clinical outcomes.
EEG scoring method 2
A second EEG reviewer randomly scanned several parts throughout the EEG in the awake state and during the first hour of sleep. He concluded whether the EEG had the same, a lower, or a higher number of IEDs compared to the other EEG of the same patient. The reviewer was blinded for the clinical outcome.
We assumed that observed changes would be more reliable when the results of EEG scoring method 1 and EEG scoring method 2 would be congruent. Furthermore, EEG scoring method 2 resembles the daily practice of patient care.
Background analysis
Because of the ambulatory registration, it was not possible to obtain artefact-free EEG fragments in the awake state with eyes closed for a spectral analysis. We only applied 3 global categories by visual inspection to describe the baseline EEG. These were: normal background, moderate background abnormalities (increased amount of diffuse slow activity with a preserved occipital rhythm with normal or decreased frequency), and severe background abnormalities (diffuse slowing of the EEG and absence of occipital rhythms).
Patient selection
We analyzed 34 patients, aged 1-45 years, included in the prospective study between January 2005 and September 2010.
Initially, 45 patients with refractory epilepsy who were candidates for the KD were included. In two patients an EEG could not be performed because of a safety helmet in one and behavioural problems in the other patient. One patient died of epilepsy-related complications before the second EEG. In 7 patients, the second EEG was not registered because the diet was discontinued within 6 weeks after the baseline EEG, as a result of side-effects and/or the burden of the diet. In three patients, the second EEG was recorded; however the diet was discontinued before sufficient clinical follow-up had been established as was required in our study design, i.e. within two months after the 4-week introduction of the diet. Of these three, one patient had unacceptable gastro-intestinal side-effects. In the other two patients, severe seizure aggravation, not expected from earlier seizure observations (occurrence of at least twice as many seizures in both patients and additional frequent non-convulsive epileptic status in one of them), led to early discontinuation. We decided to analyze these two patients as non-responders.
Statistics
We used Mann-Whitney U test (MWU) for calculating differences between groups, Spearman's correlations for correlations between 2 variables, and Pearson Chi-square test (2-sided) to test differences in proportions. Results were considered significant if alpha was 0.05.
Results
Baseline data
The data of the 34 patients are shown in Tables 1a-1c. 62% of the patients were children. 75% had at least several seizures a week, and about half of the patients had one or more daily seizures 24 Patients were on the KD for at least 6 months, 8 patients discontinued the diet between 2 and 6 months following the 4 weeks of KD introduction, and 2 patients discontinued the diet between the end of the 4 weeks of KD introduction and 2 months follow-up. Seizure diaries were complete for 25 patients at baseline and 23 patients at follow-up. In 11 patients the clinical response to the diet had to be defined by the treating physician because of incomplete diaries. 88% of the patients had IEDs in the baseline awake EEG and 76% of the patients had IEDs in the baseline sleep EEG. 21 Patients had no or only sporadic IEDs (1%) at baseline in the awake state.
There was a trend towards correlation between baseline seizure frequency and IED index (wakefulness Spearman's R = 0.37 p = 0.07; sleep Spearman's R = 0.36 p = 0.09). 76% of the EEGs showed a moderate to severe background abnormality. The severity of background abnormality was correlated to baseline seizure frequency (Spearman's R = 0.45 p = 0.02), and to baseline IED index in wakefulness (Spearman's R = 0.36 p = 0.04) and in sleep (Spearman's R = 0.35 p = 0.05).
Results after KD introduction
3.2.1. Seizure outcome 9/34 patients (26%) were clinical responders (50% seizure reduction), of whom 7 were children. In 7 of the clinical responders the response was diary-defined, in 2 physician-defined because of an incomplete diary. They all had had a follow-up period of 6 months. The 7 responders with diaries showed a clear seizure reduction from the second month of treatment which lasted until 6 months of follow-up, resulting in a mean seizure reduction of 50% during 6 months, compared to the 2 months baseline period.
The mean baseline monthly seizure frequency in these 7 responders with diaries was 88.6 (SD 78.3) and in 16 nonresponders with diaries 60.4 (SD 84.0). Mean seizure frequency in the follow-up period in 7 responders was 12.4 (SD 23.4) and in 16 non-responders with diaries 68.9 (SD 85.2). Mean age of clinical 
responders was 10.9 (SD 12.1) and of non-responders 18.3 (SD 11.2). Mean duration of epilepsy in clinical responders was 6.6 years (SD 5.4) and in non-responders 13.0 years (SD 11.0). There was no correlation between the clinical response to the KD and baseline seizure frequency. There was a correlation between the clinical response to the KD and younger age (R = 0.34 p = 0.05) and a trend towards correlation between the clinical response and shorter duration of epilepsy (R = 0.31 p = 0.08).
EEG analysis at group level
A summary of the main findings is presented in Table 2 . 31 patients were in a ketotic state on the day of the EEG. In 2 patients ketosis was measured within the two days of the EEG and in 1 patient one week after the EEG. Since these values confirmed a ketotic state we assumed that this was also the case on the day of the EEG.
AED daily doses were unchanged between the two EEG's except for one patient with a minimal dose reduction of one AED.
We did not find correlations between the severity of EEG background slowing at baseline or the IED index at baseline and response to the KD. There was no correlation between the baseline IED index and the % of seizure reduction.
We found a positive correlation between the % of IED reduction in sleep at 6 weeks and the % of seizure reduction in the follow-up period (Spearman's R = 0.56 p = 0.04) (see Fig. 2 ) but not for IED reduction in wakefulness (Spearman's R = 0.2 p = 0.4).
We did not find a change in mean IED index after 6 weeks KD, in either wakefulness or in sleep (n = 34 patients MWU wakefulness p = 0.67, n = 33 patients MWU sleep p = 0.78). Mean awake IED index at follow-up was 6.3% (SD 17.0%) vs. baseline index 6.3% (SD 18.6%) and mean sleep IED index at follow-up was 14.8% (SD 24.3%) vs. baseline index 15.1% (SD 25.8%).
EEG analysis at individual level
In 4/34 patients, no IEDs were seen during the 24-h EEG at baseline or at follow-up according to EEG scoring method 1 (2 responders, 2 non-responders). In the remaining 30 patients with IEDs in wakefulness (7 clinical responders, 23 clinical nonresponders), and in the 26 patients with IEDs during sleep (7 clinical responders, 19 non-responders), we analyzed which proportions of responders vs. non-responders had changes in IED index at follow-up.
3.2.3.1. Individual analysis of the EEG in wakefulness. Disappearance of IEDs in wakefulness according to EEG scoring method 1 was observed in 6 patients (2 responders, 4 non-responders). They had very low baseline IED indices between 0.01 and 1.22%. In these patients with low baseline index, there was a discrepancy in confirming lack of IEDs at baseline or follow-up between EEG scoring methods 1 and 2. EEG scoring method 2 confirmed the lack of IEDs at follow-up in 2 of the 6 patients identified by scoring method 1. In these 2 patients, however, method 2 had not observed IEDs in the baseline EEG either.
Twelve out of 30 patients (2/7 responders, 10/23 nonresponders) had a reduction (not disappearance) of IEDs according to method 1. This did not distinguish responders from nonresponders (p = 0.48). EEG scoring method 2 confirmed the reduction of IEDs in 6 of these patients with proportional reductions in excess of 20%. EEG scoring method 2 did not distinguish between responders and non-responders (2/7 responders, 4/23 non-responders (p = 0.52).
Disappearance of IEDs or IED-reduction according to method 1 was observed in 4/7 responders with IEDs at baseline and in 14/23 non-responders (not significant p = 0.86).
In order to compare our findings with the findings in the study by Kessler et al, 14 we examined which patients had a proportional reduction of at least 10% in wakefulness according to method 1. This did not distinguish the responders (4/7) from non-responders (13/ 23) (p = 0.98). Nor could we distinguish between responders and non-responders when higher proportional reductions were required.
Individual analysis of the EEG in sleep.
Among the 26 patients with IEDs in sleep at baseline, there were no patients in whom IEDs disappeared. We observed a reduction of IED index according to EEG scoring method 1 in 12/26 patients (5/7 responders and 7/19 non-responders (p = 0.12). The 7 non-responders had a higher mean baseline index (32.3% SD 24.8) than the 5 responders (4.1% SD 4.3%), which was the attribution of 4 non-responders with high baseline index in sleep between 18.9 and 87.9%. The other 3 non-responders were comparable to the responders with a mean baseline index of 3.4% (SD 3.2%). Although these data seem to point to a better result of the KD in patients with low IED index in sleep, this was not proved (see above ''EEG analysis at group level''). EEG scoring method 2 found a reduction of IEDs in 5/7 responders and in 5/19 non-responders, which was a significant difference (p = 0.04).
EEG scoring method 2 confirmed the reduction of IEDs found by method 1 in 9 of the 12 patients (4 responders, 5 non-responders). In the 3 patients in whom EEG method 2 did not confirm the IED reduction, this was explained by a very low baseline sleep index <1% in 2 patients (1 responder, 1 non-responder), and by a very low IED reduction of 0.81% (proportional reduction 11.9%) in 1 patient with baseline index 6.9%.
We finally examined whether a certain proportional reduction of the IED index during sleep could identify responders. We found a significant difference between responders and non-responders when a proportional reduction of at least 30% was required, which was observed in 4/7 responders vs. 3/19 non-responders (p = 0.04). All these 7 patients also had proportional reductions in wakefulness exceeding 20%. The syndromal diagnoses of the 4 clinical responders with at least 30% proportional reduction in nocturnal IED index were: cryptogenic localization related epilepsy n = 2, symptomatic epilepsy after cerebral trauma n = 1, symptomatic epilepsy after asphyxia n = 1. They were 3 children and 1 adult. They all had focal interictal epileptiform activity.
Patients with increase in IED index.
We examined whether an increase in IED index would be observed more frequently in non-responders than in responders. In wakefulness this was observed in 3/7 responders and in 9/23 non-responders according to EEG scoring method 1 (p = 0.86). EEG scoring method 2 identified 2/7 responders with increase in IEDs in wakefulness vs. 8/23 non-responders (p = 0.76). Increase in IED index in sleep according to EEG scoring method 1 was observed in 2/7 responders and 12/23 non-responders (p = 0.27). EEG scoring method 2 observed 11 patients (1 responder, 10 non-responders) with increase in IEDs (p = 0.16).
Discussion
Nine of 34 patients (7 children and 2 adults) were clinical responders, which represent a responder rate of 26% (33% in the children, 15% in adults). There were no baseline EEG features that characterized future clinical responders. At a group level we identified a correlation between a nocturnal reduction of IEDs at 6 weeks and a seizure reduction in the follow-up period. More relevant for clinical practice are changes in an early EEG at the individual level. At six weeks, EEG scoring method 1 (IED counts) found that a 30% proportional reduction of the IED index in sleep at 6 weeks, was seen more often in responders than in nonresponders. EEG scoring method 2 (global reviewing) also found a significantly larger proportion of patients showing IED reduction in sleep within the group of clinical responders. The fact that the two different types of EEG scoring methods found a significant correlation between IED reduction in sleep and clinical response, adds to the reliability of finding this correlation. We observed that global reviewing is less sensitive for the detection of changes. It detected changes when spike-counts had resulted in 20% IED reduction from baseline. The only clinical correlation we observed was correlated with 30% IED reduction from baseline. Therefore, global reviewing (as it is performed in clinical daily practice), may be a good alternative for the time-consuming method of counting individual spikes. We found however that for individual patients the observation of reduction of IEDs in this study was not a very powerful predictor, as this was also observed in 16% (method 1) to 26% (method 2) of the non-responders. We conclude that this observation cannot reliably be used to advise patients whether to continue or discontinue the diet.
We included a large proportion of patients with a low baseline IED index in wakefulness. This explains why we found the highest reductions of IEDs during sleep. In patients with a low baseline index in wakefulness, there were large discrepancies in the findings when EEG methods 1 and 2 were compared. This illustrates that outcomes on changes in this group are less reliable and are dependent on which samples of the EEG were assessed. It is not likely that reviewing every page of the awake EEG of patients with a very low IED index, would have produced a better distinction between responders and non-responders. In patients with higher baseline index (>1.22%) and with higher proportional decreases in IED index (above 20%) the two scoring methods had congruent results on detecting changes.
A weakness in studies with the EEG as outcome parameter is that there is no information on fluctuations of the IED index outside the chosen duration of the EEG registration. We performed a long-term EEG, but we were not informed on day-to-day fluctuations when treatment would not be changed. We cannot exclude that a proportional reduction of at least 30% can be a result of spontaneous fluctuations.
In 6 other studies, 4, 14, [16] [17] [18] [19] IED frequency changes after KD were analyzed and compared to a baseline. Only one study analyzed the IED index during sleep (at group level) and found a significant reduction of IEDs at 3 months, as well as a positive correlation between IED frequency reduction and seizures. This last observation corresponds to our findings. All patients in the 6 previously published studies were children. Three studies examined individual EEG changes in responders vs. non-responders during wakefulness. Remahl et al. 17 described an IED reduction in 8/16
responders vs. 5/7 non-responders (not significant). Dressler et al. 18 found disappearance of IEDs in 9/25 responders vs. Finally, earlier studies included only children, this study also adults. The differences in the epilepsy syndromes, EEG-types and ages probably explain the different findings in the studies.
From the combined results of all studies, it is clear that decreases in IED index can be found in a repeated EEG in individual patients on the KD with some correlation with the effect of the KD. Changes in IED index are best observed in patients with epilepsy syndromes with high baseline IED index. The studies show however that at an individual level, the method of performing an early EEG to predict whether the patient will be a responder, is not conclusive. Furthermore, in our study a clear and stable seizure reduction in the clinical responders could already be observed in the second month of KD treatment. Hence, in our patient group, an early EEG at 6 weeks as a predictor of future seizure reduction, was not necessary. Kessler 14 commented that ''the practical utility of performing an early EEG as predictor, may be limited to those patients whose seizure reduction on the KD is not immediate''. The number of patients with a delayed reduction of seizures in this study was, however, not mentioned. There are several studies confirming that early seizure reduction (from the 1st month of treatment) is seen far more often than delayed seizure reduction (Coppola et al. 1 , Bergvist et al. 20 , Mosek et al. 21 ).
In our study, we did not observe complete normalization of the EEG in patients with a baseline IED index exceeding 1.22%. Some studies mention abolition of frequent IEDs after KD, for example, in patients with West syndrome and hypsarrhythmia. 22, 23 Nikanorova et al. 24 studied 4 children with CSWS (syndrome of continuous spike waves in slow wave sleep) in whom IEDs were recorded during sleep in 85% of the time. After 12 months of treatment, the EEG had normalized in one patient, slightly improved in one patient and not improved in 2 patients. The real ''EEG-responder'' showed a slight increase in IQ scores, disappearance of aggression and an improvement in concentration at that time. When clinical effects are subtle and not (yet) obvious, the normalization of the EEG may encourage such patients to continue the KD. The previously mentioned studies show that effects of the KD on the EEG could be more profound in certain syndromes. In patients with GLUT-1 deficiency (the best known indication for the KD), reduction of IEDs was reported in all 4 patients who showed IEDs at baseline, of whom 3 had >90% seizure reduction (1 had never experienced seizures). 25 The baseline frequency of IEDs and the magnitude of the reduction were not mentioned in this study.
Conclusion
Although we observed a correlation between seizure reduction and IED reduction during sleep at group level, we found no evidence that early EEG changes predict the efficacy of the KD in individual patients. Only in certain patients, should EEG registra-tion before and after KD still be considered. These are patients with highly frequent interictal epileptic discharges which are a major goal of treatment, such as patients with hypsarrhythmia or ESES (electrical status epilepticus of slow wave sleep). In all other patients, the observation of seizure reduction, which will most often be noted early in the follow-up period, is the best parameter for evaluating the effect of the KD.
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